Overall, a complex relationship exists between MTHFR gene polymorphism and 5-FU-based chemotherapy efficacy and toxicity in the treatment of CRC, which has many influencing factors, such as ethnic differences, chemotherapy regimen, individual folate levels, and environmental factors. Here, MTHFR is linked to colorectal carcinoma.